Jin Medical Regains Nasdaq Compliance After Shares Stay Above $1 for 10 Days
Jin Medical regained compliance with Nasdaq Listing Rule 5550(a)(2) after its Class A shares closed at or above $1.00 per share for ten consecutive business days, eliminating potential delisting risk. The company operates two 230,000 sq ft plants and is constructing a 430,000 sq ft facility to boost capacity.
1. Nasdaq Compliance Restored
Jin Medical’s Class A ordinary shares closed at or above $1.00 per share for more than ten consecutive business days, meeting Nasdaq Listing Rule 5550(a)(2). This achievement removes the risk of delisting and reinforces market confidence in the stock’s stability.
2. Manufacturing Footprint Expansion
The company currently operates two manufacturing plants totaling approximately 230,000 square feet in Changzhou and Taizhou, Jiangsu Province. Jin Medical is also developing a 430,000 square‐foot facility in Chuzhou, Anhui Province to increase production capacity and support future growth.
3. Strategic Focus and Operations
With compliance restored, Jin Medical will continue advancing its core business operations and strategic initiatives in rehabilitation medical equipment. The firm’s product line includes over 30 wheelchair models marketed through more than 40 domestic distributors and over 20 international partners, primarily in Japan and China.